Skip to content
MarketScale
‹ Back to IndustriesHealthcare

July Job Report Reveals Records and Reservation

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June. Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June.

Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed Dow Jones and Moody’s expectations, at 148,000 for the month.

The strong job numbers are, however, a departure from consistent payroll increases of 200,000-plus the country experienced in 2018 and the first quarter of 2019. So far this year, average monthly job additions stand at 165,000, according to the Wall Street Journal. Analysts continue to point towards a trend stagnation in job growth for the remainder of the fiscal year.

Looking Ahead by Looking Back

Professional and technical services added 30,800 jobs and the health care sector added 30,400 accounting for two of the biggest payroll growths in July. Financial activities payrolls rose by 18,000 while the mining industry reported a loss of 5,000 jobs.

Today’s jobs report also significantly revised earlier numbers from what was supposedly a strong month of growth in June. The June payroll gain of 224,000 was reduced to 193,000. May’s sluggish job numbers have also been reduced from the reported 72,000 jobs down to 62,000.

Photo courtesy of the United States Bureau of Labor Statistics.

The record increase in workforce participation comes amid news that retailers like Lowe’s, which just announced thousands of layoffs at its stores, are continuing to close and reduce costs. This year alone, more than 7,000 store closures have been announced by US retailers–a staggering number that some analysts predict could reach up to 12,000 by the end of the year.

Who’s Winning, Who’s Losing?

Small businesses, specifically those with less than 20 employees, reported negative payroll numbers for the third consecutive month. They continue to struggle with labor shortages and competition from online retailers that are contributing to this decline.

Manufacturing employment had another month of modest job growth, with the country adding 16,000 new jobs. The American manufacturing industry has seen one of the most difficult periods for job growth over the past two quarters. This report comes in the midst of ongoing trade disputes and softening of the global market. US manufacturing work hours hit its lowest mark since 2011.

In the wake of a new round of tariffs on China, set to go in effect September 1st, the trade deficit between the two countries decreased 0.3% to 55.2 billion. Markets will be vigilant of the impact this new round of tariffs will have on American consumers along with worries of a global economic slowdown as the Federal Reserve voted Wednesday to cut their interest rate a quarter of a percent.

For the latest news, head to our industries pages! You can also follow us on Twitter @MarketScale for up-to-the-minute updates! Join the conversation in on Market Leaders LinkedIn Groups!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512